- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Infographics
- Learning Tracks
- Podcasts
- Shareable/Downloadable Content
- Videos
- PsychUSim
- PsychU Roleplay
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Psychiatric Scales
- Psychopharmacology
- Supporting Organizations
Virtual Event – Current Guidelines & Unmet Needs In The Treatment Of Agitation Associated With Alzheimer’s Dementia
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Current Guidelines & Unmet Needs In The Treatment Of Agitation Associated With Alzheimer’s Dementia
This is a Virtual Event for PsychU members in Indiana, Kentucky, and Ohio.
Individualized and multimodal treatment plans are recommended for patients with Alzheimer’s disease and Agitation associated with Alzheimer’s Dementia (AAD). There is a need for better identification of AAD. There is also a need for approved pharmacological treatments that have proven and favorable benefit, risk profiles to reduce symptoms and ultimately improve burden to caregivers and healthcare.
In this discussion, current treatment guidelines, assess risk/benefit profile, and discuss unmet needs of AAD treatment will be reviewed.
Featuring
Elizabeth DiNapoli, PhD (OPDC)
Senior Medical Science Liaison
MoreDr. DiNapoli earned her PhD from the University of Alabama.Alex Matushek, PharmD, MBA (OPDC)
Medical Science Liaison
Speakers Elizabeth DiNapoli, PhD and Alex Matushek, PharmD, MBA are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Related Events
-
Virtual Event – Born This Way? The Role Of Early Life Stress In Adult Mental Illness
March 20 12:00 pm to 1:00 pm
Registration
Related Resources
-
Treatment Considerations For Agitation In Alzheimer’s Dementia
Infographic February 13, 2025The Investigate/Plan/Act approach to Agitation evaluation, management, and prevention.
-
Digital Dialogue Series Part 2
Interview February 10, 2025Digital Therapeutics are health software that treat or alleviate a condition by generating and delivering an intervention. This mini series aims to deepen our understanding of this innovation.
-
Incorporating Digital Therapeutics into the Patient Journey
On-Demand Webinar February 7, 2025Join us for an insightful webinar exploring digital therapeutics (DTx) as innovative, nonpharmacologic treatment options for mental health conditions.
Event Navigation
- « Virtual Event – Pathophysiology Of Agitation Associated With Alzheimer’s Dementia (AD) – The Potential Role Of The Norepinephrine, Serotonin & Dopamine (NSD) Neurotransmitter Systems
- Virtual Event – Current Guidelines & Unmet Needs In The Treatment of Agitation Associated With Alzheimer’s Dementia »
Join today for instant access to all PsychU content, events, and more!
Membership is free!
"*" indicates required fields
Join PsychU Today to receive a wide array of tools and benefits
- Join our multidisciplinary community that is improving mental health care… together
- Quickly learn more about the topics you're interested in
- Access an award-winning library of on-demand mental health resources
- Gain key insights from industry expert & thought leaders
Stay Connected: